Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Banyu: Nu-lotan Boosts Sales, but Profits Down due to Loss Caused by Securities Sale
December 3, 2001
- Korosho Requires Inspections of Hollow-fiber Dialyzers
December 3, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -1-
December 3, 2001
- GEYMS: Top of the Line LOGIQ Ultrasound Device Introduced
December 3, 2001
- Listed Wholesalers' Profits Plummet Despite Increases in Sales
December 3, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 3, 2001
- BUSINESS NEWS IN BRIEF
December 3, 2001
- WORLD NEWS IN BRIEF
December 3, 2001
- Aiming at \2 Trillion Sales in FY2009: Kuraya Sanseido President
December 3, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
December 3, 2001
- Kissei Withdraws Additional Indication Application for Rizaben
December 3, 2001
- DIAGNOSTIC NEWS IN BRIEF
November 26, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -2-
November 26, 2001
- WORLD NEWS IN BRIEF
November 26, 2001
- BULLETIN
November 26, 2001
- The 39th Annual Meeting of Japan Society of Clinical Oncology
November 26, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -1-
November 26, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
November 26, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -3-
November 26, 2001
- OTC NEWS IN BRIEF
November 26, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…